Semaglutide, the first dedicated GLP-1 obesity treatment, achieved 14.9% body weight reduction in the STEP 1 trial
Healthy stem cell processes*
They want to know whether GHK-Cu may fit the concern that brought them to the consultation
Originally isolated from human gastric juice in the early 1990s by Croatian researchers, this 15-amino acid peptide has demonstrated an almost paradoxical ability to promote healing across diverse tissue types throughout the body
Studied in preclinical models for tendon, ligament and tissue repair, angiogenesis and gut-lining protection
In animal experiments, obese mice treated with 5-Amino-1MQ lost approximately 5.1% of their body weight over 11 days, without a decrease in food intake, suggesting that its effect is mainly due to metabolic changes rather than appetite suppression